GlassScriptPhysician profile
Shuchi Parikh
NPI 1255899605
$2,288.86
in general payments reported to CMS, 2019-2025
16 companies · $651 in 2025
The $651 reported for 2025 was more than what 79% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $202 · 2022: $49.54 · 2023: $734 · 2024: $653 · 2025: $651.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,037.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,037.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $794.99 | 2023-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $420.61 | 2021-2025 | Verquvo, Capvaxive |
| Amgen INC. | $234.07 | 2021-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $214.34 | 2022-2025 | |
| Astellas Pharma US INC | $154.39 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.10 | 2021-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $88.53 | 2023-2024 | Xarelto |
| Lexicon Pharmaceuticals, INC. | $64.45 | 2023 | Inpefa |
| Travere Therapeutics, INC. | $40.60 | 2023 | |
| Teleflex LLC | $30.74 | 2023 | Guideliner |
| Sanofi-Aventis U.S. LLC | $24.00 | 2024 | |
| Boston Scientific Corporation | $23.97 | 2021 | |
| Altathera Pharmaceuticals LLC | $20.52 | 2025 | Sotalol Hydrochloride |
| Pfizer INC. | $19.45 | 2025 | |
| Cleerly, INC. | $18.70 | 2025 | Cleerly Ischemia, Cleerly Labs |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $15.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shuchi Parikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.